Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.38 -0.18 (-5.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Cash & Equivalents (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) recorded Cash & Equivalents of $510.1 million in Q2 2026, down 29.3% from $721.45 million a year earlier and down 8.8% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2025, Bicycle Therapeutics reported Cash & Equivalents of $628.11 million, down 28.6% from FY2024.

  • Annual Cash & Equivalents has a five-year compound annual growth rate of 35.8% (FY2020 to FY2025).
  • Across earlier years, Cash & Equivalents came in at $879.52 million in FY2024 (+67.1%), $526.42 million in FY2023 (+55.2%), $339.15 million in FY2022 (-22.7%) and $438.68 million in FY2021 (+222.6%).
  • The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2024.
  • On a year-over-year basis, Cash & Equivalents has declined for five consecutive quarters, with growth averaging 7.1% over the last eight quarters.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 222.6% in Q4 2021, against a decline of 29.4% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $559.5 million (Q1 2026), $628.11 million (Q4 2025) and $648.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Bicycle Therapeutics 248.54 Mn 248.54 Mn - 510.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 510.10 Mn
Mar 31, 2026 559.50 Mn
Dec 31, 2025 628.11 Mn
Sep 30, 2025 648.33 Mn
Jun 30, 2025 721.45 Mn
Mar 31, 2025 792.97 Mn
Dec 31, 2024 879.52 Mn
Sep 30, 2024 890.86 Mn
Jun 30, 2024 961.36 Mn
Mar 31, 2024 457.00 Mn
Dec 31, 2023 526.42 Mn
Sep 30, 2023 572.09 Mn
Jun 30, 2023 340.43 Mn
Mar 31, 2023 293.82 Mn
Dec 31, 2022 339.15 Mn
Sep 30, 2022 361.47 Mn
Jun 30, 2022 372.80 Mn
Mar 31, 2022 407.40 Mn
Dec 31, 2021 438.68 Mn
Sep 30, 2021 259.52 Mn
API Access

Bicycle Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCYC&period=max&api_key=YOUR_API_KEY